Fermenta Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	413.43	282.4	218.29	352.91	130.56
Short-Term Investments	-	424.2	379.95	247.68	126.37
Cash & Short-Term Investments	413.43	706.59	598.24	600.59	256.93
Cash Growth	-41.49%	18.11%	-0.39%	133.75%	-29.35%
Accounts Receivable	1,172	1,041	729.75	448.69	870.9
Other Receivables	-	153.18	9.39	3.51	79.03
Receivables	1,173	1,205	785.78	462.45	950.08
Inventory	1,525	1,329	890.75	1,312	1,733
Prepaid Expenses	-	23.27	51.7	26.77	27.85
Restricted Cash	-	-	0	3.84	0.13
Other Current Assets	768.3	88.96	91.07	125.02	172.01
Total Current Assets	3,880	3,352	2,418	2,530	3,140
Property, Plant & Equipment	2,233	2,322	2,535	2,585	2,373
Long-Term Investments	4.19	4.86	4.43	3.76	48.93
Goodwill	41.17	41.17	41.17	115.3	109.55
Other Intangible Assets	26.17	29.98	71.55	132.72	175.95
Long-Term Deferred Tax Assets	183.59	286.44	219.99	332.58	359.94
Long-Term Deferred Charges	-	0.82	1.15	-	0.16
Other Long-Term Assets	99.07	105.38	184.8	664.14	860.34
Total Assets	6,479	6,145	5,478	6,365	7,068
Accounts Payable	771.5	774.87	649.04	457.95	645.8
Accrued Expenses	-	49.94	81.86	40	68.96
Short-Term Debt	1,010	812.4	673.42	1,015	974.75
Current Portion of Long-Term Debt	-	131.13	223.93	318	239.88
Current Portion of Leases	12.63	10.92	9.58	6.87	10.7
Current Income Taxes Payable	18.43	44.11	3.41	3.25	3.2
Current Unearned Revenue	17.3	190.09	3	0.95	-
Other Current Liabilities	258.02	105.31	88.36	245.6	127.94
Total Current Liabilities	2,088	2,119	1,733	2,087	2,071
Long-Term Debt	78.99	150.48	425.36	835.89	1,147
Long-Term Leases	31.81	44.44	55.39	19.91	19.68
Pension & Post-Retirement Benefits	-	41.38	25.62	21.43	18.85
Other Long-Term Liabilities	275.39	204.54	387.7	275.1	97.32
Total Liabilities	2,474	2,560	2,627	3,240	3,354
Common Stock	143.35	145.85	144.37	144.29	144.24
Additional Paid-In Capital	-	171.23	23.69	15.28	-
Retained Earnings	-	3,628	2,903	3,169	3,618
Comprehensive Income & Other	3,919	-318.36	-182.93	-174.98	-41.28
Total Common Equity	4,062	3,627	2,889	3,153	3,721
Minority Interest	-56.68	-41.57	-36.98	-27.49	-6.83
Shareholders' Equity	4,005	3,585	2,852	3,126	3,715
Total Liabilities & Equity	6,479	6,145	5,478	6,365	7,068
Total Debt	1,133	1,149	1,388	2,195	2,392
Net Cash (Debt)	-719.86	-442.76	-789.44	-1,595	-2,135
Net Cash Per Share	-24.59	-15.18	-27.34	-55.26	-73.61
Filing Date Shares Outstanding	28.81	29.43	29.43	28.86	28.85
Total Common Shares Outstanding	28.81	29.43	29.43	28.86	28.85
Working Capital	1,792	1,234	684.93	443.05	1,069
Book Value Per Share	140.98	123.23	98.15	109.27	129.00
Tangible Book Value	3,995	3,556	2,776	2,905	3,436
Tangible Book Value Per Share	138.64	120.81	94.32	100.67	119.10
Land	-	3.43	3.43	3.43	3.43
Buildings	-	1,010	1,007	717.57	701.21
Machinery	-	2,140	2,101	1,892	1,799
Construction In Progress	-	159.07	16.16	419.03	298.93
Leasehold Improvements	-	59.13	211.64	211.64	49.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.